九价人乳头瘤病毒住院产后疫苗接种:临床指南实施
本研究在一家学术性城市转诊中心产科,对26岁及以下产后住院患者实施九价HPV(9vHPV)住院疫苗接种方案,并回顾性评估2021年3月至2022年3月的实施情况。569例产后住院患者中,370例(65.0%)孕前已接种,疫苗 eligible 患者中46例(23.1%)接受住院接种。在多变量分析中,接受认证助产实践照护是疫苗 eligible 患者接种的唯一独立预测因素(OR 2.4,95%CI 1.02-5.74,P=.04)。住院产后9vHPV疫苗接种可能有助于缩小接种差异。
要点
- 569例产后住院患者中,370例(65.0%)孕前已接种9vHPV疫苗。
- 疫苗 eligible 患者中,46例(23.1%)接受住院产后9vHPV疫苗接种。
- 疫苗 eligible 患者中,接受认证助产实践照护是接种的唯一独立预测因素(OR 2.4,95%CI 1.02-5.74,P=.04)。
核心结论
- 非西班牙裔白人、西班牙语使用者和已婚患者在基线人群中接种不足比例偏高,但约四分之一的疫苗 eligible 患者产后接受了9vHPV疫苗接种。
- 住院产后9vHPV疫苗接种可能有助于缩小接种差异。
研究设计与样本
- 对一家学术性城市转诊中心产科专业人员发送电子邮件方案,概述针对26岁及以下产后住院患者的新型9vHPV疫苗接种计划。
- 进行2021年3月至2022年3月的回顾性评估以评价实施情况。
- 采用χ2检验、方差分析和多变量逻辑回归比较孕前已接种患者与疫苗 eligible 患者(未接种、状态未知或部分接种)的特征。
- 同样分析比较疫苗 eligible 患者中接受与未接受住院9vHPV疫苗接种者的特征。
主要发现
- 569例产后住院患者中,370例(65.0%)已接种,70例(34.2%)从未接种,49例(24.6%)部分接种,80例(14.1%)状态未知。
- 疫苗 eligible 患者中,46例(23.1%)接受住院9vHPV疫苗接种。
- 多变量分析中,种族和民族、婚姻状况和主要语言是孕前接种的显著预测因素。
- 疫苗 eligible 患者中,住院接种者主要为西班牙裔、西班牙语使用者和公共保险参保者。
- 疫苗 eligible 患者的多变量分析中,接受认证助产实践照护是接种的唯一独立预测因素(OR 2.4,95%CI 1.02-5.74,P=.04)。
临床怎么用
- 住院产后9vHPV疫苗接种可能有助于缩小接种差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The nine-valent human papillomavirus (9vHPV) vaccine is highly effective at preventing cervical cancer, yet U.S. vaccination rates remain low. The objective of this study was to evaluate integration of 9vHPV inpatient vaccination into routine postpartum care. METHODS: Obstetrics professionals at an academic urban referral center received an emailed protocol outlining a novel 9vHPV vaccination program of postpartum inpatients aged 26 years or younger. A retrospective evaluation from March 2021 to March 2022 was conducted to evaluate implementation. Characteristics of patients vaccinated before pregnancy compared with vaccine-eligible patients (none, unknown, or partially vaccinated status) were compared by the use of χ2, analysis of variance, and multivariable logistic regression. Similarly, analyses were performed comparing vaccine-eligible patients who did with those who did not receive an inpatient 9vHPV vaccination. RESULTS: Of 569 postpartum inpatients, 370 (65.0%) were already vaccinated, 70 (34.2%) were never vaccinated, 49 (24.6%) were partially vaccinated, and 80 (14.1%) had unknown status. Of vaccine-eligible patients, 46 (23.1%) received 9vHPV vaccination as an inpatient. In multivariable analysis, race and ethnicity, marital status, and primary language were significant predictors of vaccination before pregnancy. Among vaccine-eligible patients, inpatient vaccination recipients were primarily Hispanic, Spanish speaking, and publicly insured. In multivariable analysis of vaccine-eligible patients, receiving care from the certified nurse midwifery practice was the only independent predictor of vaccination (odds ratio 2.4, 95% CI 1.02-5.74, P=.04). CONCLUSION: Non-Hispanic White, Spanish-speaking, and married patients were disproportionally undervaccinated in our baseline population, but about one quarter of vaccine-eligible patients received 9vHPV vaccination postpartum. Inpatient postpartum 9vHPV vaccination may help narrow disparities in vaccination.
引用
- Murphy EC, Alimena S, Pelletier A, et al. Human Papillomavirus Inpatient Postpartum Vaccination: Clinical Guideline Implementation. Obstet Gynecol. 2023. PMID: 37348091. doi:10.1097/AOG.0000000000005220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。